Venlor XR 37.: Compound Profile
Venlor XR 37.5 mg Cipla is a pharmaceutical-grade extended-release formulation containing venlafaxine hydrochloride, manufactured by Cipla for laboratory research applications. This compound represents a dual-acting serotonin-norepinephrine reuptake inhibitor (SNRI) utilised in neuropharmacological studies examining monoamine transporter mechanisms. The extended-release matrix formulation enables researchers to investigate sustained compound release kinetics and bioavailability profiles in controlled laboratory environments. Scientists at Stroid UK Shop source this pharmaceutical reference material for studies requiring precise venlafaxine concentrations over extended timeframes.
Laboratory Applications
Researchers investigate Venlor XR in neurotransmitter reuptake studies, examining its selective inhibition of serotonin and norepinephrine transporters. The compound’s dual mechanism makes it valuable for comparative pharmacokinetic research alongside other antidepressant classes. Laboratory studies utilise this formulation to examine extended-release matrix dissolution rates, tablet integrity under various pH conditions, and compound stability profiles. The pharmaceutical-grade purity ensures consistent results in analytical chemistry protocols. Research teams studying monoamine oxidase interactions frequently examine this compound alongside other venlafaxine formulations to establish comparative efficacy profiles in preclinical models.
Technical Specifications
| Active Ingredient | Venlafaxine HCl 37.5mg |
|---|---|
| Formulation | Extended-Release Tablet |
| Manufacturer | Cipla Limited |
| CAS Number | 99300-78-4 |
| Molecular Formula | C₁₇H₂₈ClNO₂ |
| Storage Conditions | Room temperature, dry environment |
Comparative studies with selective androgen receptor modulators and research peptides demonstrate distinct pharmacological profiles across different compound classes, highlighting the importance of pharmaceutical-grade reference standards in laboratory research.
Research Compliance Statement
Venlor XR 37.5 mg Cipla is supplied strictly for in-vitro laboratory research purposes only. This pharmaceutical reference material is intended for qualified research institutions and laboratories conducting studies on neurotransmitter reuptake mechanisms, extended-release formulation development, or comparative pharmacokinetic analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and local regulations governing pharmaceutical research materials.
